Scotia Vision LLC, a global life science consulting partner to pharmaceutical, drug delivery and device companies, announced Monday that it has entered into a definitive merger agreement with i2eye Consulting LLC, a US based firm and provider of commer…
Category: News
SARcode Corporation To Present Phase 2 Clinical Data For Dry Eye Candidate At The ARVO2011 Annual Meeting
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-May 5, 2011, in…
SARcode Corporation To Present Phase 2 Clinical Data For Dry Eye Candidate At The ARVO2011 Annual Meeting
SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-May 5, 2011, in…
DSAEK Grafts Yield Greater Thickness, Haze Than PK
Patients who underwent Descemet’s stripping automated endothelial keratoplasty had increased corneal thickness and significantly more haze during follow-up than those who underwent penetrating keratoplasty, a study showed.
Progress Seen In Creating Eye Cells From Stem Cells
To push the theoretical promise of stem cell research into the world of viable treatments, scientists have successfully fashioned adult stem cells into the kind of eye cells that fall victim to the onset of age-related macular degeneration, or AMD.
Progress Seen In Creating Eye Cells From Stem Cells
To push the theoretical promise of stem cell research into the world of viable treatments, scientists have successfully fashioned adult stem cells into the kind of eye cells that fall victim to the onset of age-related macular degeneration, or AMD.
Self-Adjustable Glasses Voted Most Likely To Make The Biggest Impact On Healthcare By 2020 At Healthcare Innovation Expo
Professor Josh Silver’s self-adjustable glasses have been voted the idea most likely to make the biggest impact on healthcare by 2020 at the Healthcare Innovation Expo…
Canon’s New TX-20P Full-Auto Tonometer
Canon has unveiled a prototype of its TX-20P fully automatic non-contact tonometer that also features a pachymeter for measuring the thickness of the cornea.
The Canon TX-20P Full-Auto Tonometer is designed to capture the complete automated measureme…
Fining Unwashed Hands — A Dirty Trick?
Physicians discuss an aggressive campaign to increase handwashing, which uses fines to enforce this important practice. Medscape Family Medicine
InSite Vision Announces Positive Phase 1/2 Results For ISV-303 For The Reduction Of Pain And Inflammation After Cataract Surgery
InSite Vision Incorporated (OTCBB:INSV) announced top-line results from its recently completed Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery…
AAAAI: Inhaled Steroid No Threat to Vision (CME/CE)
SAN FRANCISCO (MedPage Today) — The risk of cataracts among children with asthma on long-term inhaled budesonide is virtually nil, according to a study in which patients were on the steroid treatment for an average of 16 years.
LensAR™ Laser System Receives FDA Clearance For Lens Fragmentation And Anterior Capsulotomy In Cataract Surgery
LensAR, Inc., the leading developer of next-generation laser technology for refractive cataract surgery, announced that the company has received 510(k) clearance from the FDA for use of the LensAR™ Laser System for anterior capsulotomy and lens fragm…
LensAR™ Laser System Receives FDA Clearance For Lens Fragmentation And Anterior Capsulotomy In Cataract Surgery
LensAR, Inc., the leading developer of next-generation laser technology for refractive cataract surgery, announced that the company has received 510(k) clearance from the FDA for use of the LensAR™ Laser System for anterior capsulotomy and lens fragm…
Positive data from Omeros’ OMS302 Phase 2b trial in patients undergoing cataract surgery
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial…
Canon’s New TX-20P Full-Auto Tonometer
Canon has unveiled a prototype of its TX-20P fully automatic non-contact tonometer that also features a pachymeter for measuring the thickness of the cornea.
SMR, RTU enter license agreement for RESCULA eye drops
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, …
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial…
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial…
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b clinical trial…
ISTA Pharmaceuticals Highlights BEPREVE(R) Clinical Data At The 2011 American Academy Of Allergy, Asthma And Immunology (AAAAI) Annual Meeting
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced additional results from the Company’s BEPREVE(R) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. These results were presented in poster sess…